Melanoma blood test using a new device (Cytophone)
Part of Cancer, Skin clinical trials.
This trial tests a new, non-invasive device called a liquid biopsy that looks for melanoma cells in your blood. It may help find cancer earlier without needing a needle biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with melanoma (a type of skin cancer).
- You must be able to sit still for up to one hour.
- You cannot have serious heart, liver, brain, or other major health problems that could make the study unsafe.
- You cannot have a severe or ongoing infection.
- If you are a woman who could become pregnant, you must be using effective birth control and not be pregnant or planning to become pregnant.
- You cannot have a history of hard-to-treat constipation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at whether a special PET scan (FDG PET/CT) and a blood test that measures ctDNA (cancer DNA in the blood) can help predict how well immune checkpoint inhibitors work in people with advanced melanoma. If you are planning to get treatment with immunotherapy drugs like ipilimumab, nivolumab, or pembrolizumab, you may be able to join.
This study looks at whether a simple blood test can track how well immunotherapy is working in people with advanced melanoma. It might help doctors see if the treatment is effective earlier than with scans alone.
This trial tests a way to detect circulating melanoma cells (melanoma cells moving in the blood) in real time. If you have melanoma, you may be asked to take part in a session where the team measures your blood during the procedure.
This study looks at your melanoma's gene activity and a blood test for tumor DNA to help predict the risk of the cancer coming back. You will need to provide blood and tissue samples, and the goal is to find better ways to personalize treatment for people with thicker, high-risk melanomas.
This study looks at serial (repeated) tumour biopsies and blood samples in people with advanced melanoma. The goal is to understand biomarkers and disease changes over time, which may help improve future treatment decisions.
This trial is looking at a protein called CD160 on immune cells (NK cells) in melanoma patients. The goal is to understand if this protein can be a target for new treatments. By studying your blood and tumor samples, researchers hope to find better ways to treat advanced melanoma.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.